期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Ginsenoside Rc:A potential intervention agent for metabolic syndrome
1
作者 Zhengjie Lu Tongyun Mao +3 位作者 Kaiqi Chen longxin chai Yongguo Dai Kexin Liu 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2023年第12期1375-1387,共13页
Ginsenoside Rc,a dammarane-type tetracyclic triterpenoid saponin primarily derived from Panax ginseng,has garnered significant attention due to its diverse pharmacological properties.This review outlined the sources,p... Ginsenoside Rc,a dammarane-type tetracyclic triterpenoid saponin primarily derived from Panax ginseng,has garnered significant attention due to its diverse pharmacological properties.This review outlined the sources,putative biosynthetic pathways,extraction,and quantification techniques,as well as the pharmacokinetic properties of ginsenoside Rc.Furthermore,this study explored the pharmacological effects of ginsenoside Rc against metabolic syndrome(MetS)across various phenotypes including obesity,diabetes,atherosclerosis,non-alcoholic fatty liver disease,and osteoarthritis.It also highlighted the impact of ginsenoside Rc on multiple associated signaling molecules.In conclusion,the anti-MetS effect of ginsenoside Rc is characterized by its influence on multiple organs,multiple targets,and multiple ways.Although clinical investigations regarding the effects of ginsenoside Rc on MetS are limited,its proven safety and tolerability suggest its potential as an effective treatment option. 展开更多
关键词 Ginsenoside Rc Metabolic syndrome OBESITY DIABETES ATHEROSCLEROSIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部